InterCure Ltd
TASE:INCR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
InterCure Ltd
TASE:INCR
|
IL |
|
HC SemiTek Corp
SZSE:300323
|
CN |
|
P
|
PNC Process Systems Co Ltd
SSE:603690
|
CN |
|
Pason Systems Inc
TSX:PSI
|
CA |
|
Asia Vital Components Co Ltd
OTC:AVMPF
|
TW |
|
Aumann AG
XETRA:AAG
|
DE |
|
S
|
Shanghai Golden Bridge Info Tech Co Ltd
SSE:603918
|
CN |
|
P
|
Paratek Pharmaceuticals Inc
F:N4CN
|
US |
|
ATTRAQT Group plc
LSE:ATQT
|
UK |
|
V
|
Valmet Oyj
LSE:0QIW
|
FI |
|
Itausa SA
BOVESPA:ITSA4
|
BR |
|
C
|
Central African Gold Inc
OTC:NDENF
|
CA |
|
Willow Biosciences Inc
TSX:WLLW
|
CA |
|
Dream International Ltd
HKEX:1126
|
HK |
|
E
|
Everest Consolidator Acquisition Corp
NYSE:MNTN
|
US |
|
Fullwealth International Group Holdings Ltd
HKEX:1034
|
HK |
|
Kopin Corp
NASDAQ:KOPN
|
US |
Bankruptcy Probability
InterCure Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
InterCure Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
I
|
InterCure Ltd
TASE:INCR
|
114m ILS |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
855.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
228.1B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
291.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
154.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
86.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
InterCure Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, InterCure Ltd has total debt of 102.8m ILS. This includes both short-term (0 ILS) and long-term (102.8m ILS) debt.
You can find a full breakdown on its Balance Sheet.
